Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Mexican Stock Exchange  >  Genomma Lab Internacional SAB de CV    LAB B   MX01LA010006

GENOMMA LAB INTERNACIONAL SAB DE CV (LAB B)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE
Quotes 5-day view   End-of-day quote. End-of-day quote Mexican Stock Exchange
09/14/2018 09/17/2018 09/18/2018 09/19/2018 09/20/2018 Date
17.43(c) 17.42(c) 17.41(c) 17.45(c) 17.23 Last
2 803 999 2 443 115 2 467 436 2 871 901 2 031 833 Volume
+1.28% -0.06% -0.06% +0.23% -1.26% Change
More quotes
Financials (MXN)
Sales 2018 12 640 M
EBIT 2018 2 535 M
Net income 2018 1 528 M
Debt 2018 3 704 M
Yield 2018 -
Sales 2019 13 152 M
EBIT 2019 2 956 M
Net income 2019 1 471 M
Debt 2019 3 472 M
Yield 2019 2,96%
P/E ratio 2018 11,36
P/E ratio 2019 10,82
EV / Sales2018 1,74x
EV / Sales2019 1,66x
Capitalization 18 300 M
More Financials
Company
Genomma Lab Internacional SAB de CV engages in the development, manufacturing and marketing of pharmaceutical, beauty and personal care products.The company was founded on October 30, 1996 and is headquartered in México City, Mexico. 
Sector
Pharmaceuticals
Calendar
-
More about the company
Surperformance© ratings of Genomma Lab Internacional
Trading Rating : Investor Rating :
More Ratings
Latest news on GENOMMA LAB INTERNACIONAL
07/24GENOMMA LAB INTERNACIONAL DE CV : IFC and IDB Invest Will Provide a US$100 Milli..
AQ
2013GENOMMA LAB INTERNACIONAL SAB DE CV : Anuncio Wal-mart - TCP
PU
2013GENOMMA LAB INTERNACIONAL SAB DE CV : quaterly earnings release
2013Mexico's Genomma Lab to Sell Products in U.S. Wal-Mart Stores
DJ
2012GENOMMA LAB INTERNACIONAL SAB DE CV : GLI Secures Committed Financing to acquire..
PU
2011GENOMMA LAB : Termination of XL-3 License Agreement
PU
More news
Sector news : Pharmaceuticals - NEC
09/20Animal health firm Elanco surges 41 percent on debut
RE
09/20WALL STREET STOCK EXCHANGE : Aurora Cannabis plans U.S. stock listing in October
RE
09/20ELI LILLY AND : Lilly Spinoff Elanco Animal Health Surges Early in Market Debut ..
DJ
09/20ONCOMED PHARMACEUTICALS : Says Celgene Won't Exercise Option to License Navicixi..
DJ
09/20PFIZER : 20vPnC Vaccine Gets FDA Breakthrough-Therapy Designation
DJ
More sector news : Pharmaceuticals - NEC
Latest Tweets
2015Mexico's Genomma Lab sells stake in distributor unit for $88 mln  
More tweets
Qtime:10
News from SeekingAlpha
08/24Genomma Lab announces management changes 
07/25Genomma Lab International SAB DE CV reports Q2 results 
04/25Genomma Lab International SAB DE CV reports Q1 results 
2016THE DEUTSCHE X-TRACKERS MSCI MEXICO : A New World Leader? 
Chart GENOMMA LAB INTERNACIONAL SAB DE CV
Duration : Period :
Genomma Lab Internacional SAB de CV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENOMMA LAB INTERNACIONAL
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Average target price 22,6  MXN
Spread / Average Target 30%
EPS Revisions
Managers
NameTitle
Jorge Luis Brake Valderrama Chief Executive Officer
Rodrigo Alonso Herrera Aspra Chairman
Antonio Zamora Galland Vice President-Administration & Finance
Juan Alonso Independent Director
Sabrina Lucila Herrera Aspra Director
Sector and Competitors
1st jan.Capitalization (M$)
GENOMMA LAB INTERNACIONAL SAB DE CV-14.96%975
JOHNSON & JOHNSON0.59%376 820
PFIZER20.13%253 595
NOVARTIS-0.80%216 184
ROCHE HOLDING LTD.-4.06%211 637
MERCK AND COMPANY24.36%186 114